OpenAI researcher Miles Wang plans $2B AI drug discovery startup

Miles Wang, a researcher at OpenAI, is in talks to launch an AI-powered drug discovery startup valued at $2 billion. Lightspeed venture capital is in discussions to lead the funding round, according to sources familiar with the matter.